Uploaded image for project: 'Project Scope Statements/Proposals'
  1. Project Scope Statements/Proposals
  2. PSS-2127

FHIR Representation of Eligibility Criteria for Clinical Trials

    XMLWordPrintableJSON

Details

    • Icon: Project Scope Statement Project Scope Statement
    • Resolution: Unresolved
    • Icon: Medium Medium
    • None
    • Hide

      In clinical trials a study’s protocol has instructions or rules on who can or cannot participate in the study. These instructions, called eligibility criteria, describe characteristics that must be shared by all study participants. The criteria differ from study to study. Eligibility criteria include both inclusion and exclusion criteria and may be comprised of age, gender, medical history, and current health status, severity of the disease being studied, and concomitant medications. Eligibility criteria for treatment studies often require that patients have a particular indication, type of disease and stage of disease.
      There are many efforts to structure eligibility criteria for clinical trials, but none that have represented it in FHIR adequately to meet the business need. The structuring of eligibility criteria in FHIR will support several data exchange scenarios: a clinical trials registry that includes submission of eligibility criteria; supporting trial matching services; supporting the data exchange between hospital information systems and clinical trials management systems as well as trial planning efforts (including estimation of potential sample size at study sites).

      Show
      In clinical trials a study’s protocol has instructions or rules on who can or cannot participate in the study. These instructions, called eligibility criteria, describe characteristics that must be shared by all study participants. The criteria differ from study to study. Eligibility criteria include both inclusion and exclusion criteria and may be comprised of age, gender, medical history, and current health status, severity of the disease being studied, and concomitant medications. Eligibility criteria for treatment studies often require that patients have a particular indication, type of disease and stage of disease. There are many efforts to structure eligibility criteria for clinical trials, but none that have represented it in FHIR adequately to meet the business need. The structuring of eligibility criteria in FHIR will support several data exchange scenarios: a clinical trials registry that includes submission of eligibility criteria; supporting trial matching services; supporting the data exchange between hospital information systems and clinical trials management systems as well as trial planning efforts (including estimation of potential sample size at study sites).
    • Biomedical Research & Regulation
    • Clinical Decision Support
      Clinical Quality Information
    • CodeX, Vulcan
    • Hide
      PIE WG; German Medical Informatics Initiative; COVID-19 Knowledge Accelerator/Scientific Knowledge Accelerator Foundation; Computable Publishing LLC;
      European Vaccines Network; CIC WG
      Show
      PIE WG; German Medical Informatics Initiative; COVID-19 Knowledge Accelerator/Scientific Knowledge Accelerator Foundation; Computable Publishing LLC; European Vaccines Network; CIC WG
    • Computable Publishing LLC; German Medical Informatics Initiative; European Vaccines Network
    • Hide
      EMA Direct Data Capture (DDC) Initiative; ICH M11: Clinical electronic Structured Harmonised Protocol (CeSHarP);
      Show
      EMA Direct Data Capture (DDC) Initiative; ICH M11: Clinical electronic Structured Harmonised Protocol (CeSHarP);
    • Product Family Product Project Intent Lineage Ballot Type Target Cycle Actions
      1
      FHIR
      Implementation Guide
      Create New R1 Standard
       
      STU
      September 2023
      2
      FHIR
      Profile
      Create New R1 Standard
       
      STU
      September 2023
    • Structured Eligibility Criteria; Eligibility Criteria
    • Dependency on EvidenceVariable Resource work being done in CDS WG.
    • N/A
    • Yes
    • No
    • None
    • No
    • none
    • Academic/Research, Association/Goverment Agency, Consultant, Healthcare IT Vendors, Pharmaceutical/Biotech, Standards Development Organizations (SDOs), Vendor/Manufacturer
    • Universal

    Description

      This project will develop implementation guidance to support FHIR representation of Eligibility Criteria for Clinical Trials.

      The BR&R WG has been working on this use case for several months and has done extensive work discussed during weekly BR&R calls. EBM on FHIR project has also been involved in these discussions. The work-in-progress is here on BR&R WG confluence pages – https://confluence.hl7.org/pages/viewpage.action?pageId=81013279

      Examples of FHIR representation of eligibility criteria can be found at https://fevir.net/resources/Project/32444

      Attachments

        Activity

          People

            Unassigned Unassigned
            shastak Smita Hastak
            Brian S. Alper Brian S. Alper
            Khalid Shahin Khalid Shahin
            Watchers:
            12 Start watching this issue

            Dates

              Created:
              Updated: